Atlas Trials

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir

Clinical trial NCT01294761 · COMPLETED

Trial details

NCT number
NCT01294761
Sponsor
National Center for Global Health and Medicine, Japan
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HIV Infections
Start date
2011-02-01
Primary completion
2012-02-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.